EpiAxis Therapeutics to present at Biotech Showcase 2023

EpiAxis Therapeutics to present at Biotech Showcase 2023

EpiAxis Therapeutics, a leading LSD1 company with a focus on the treatment, diagnosis and monitoring of cancer and the prevention of its recurrence, is presenting at Biotech Showcase™ 2023. EpiAxis CEO Dr Jeremy Chrisp will discuss the company's focus on developing...

read more
EpiAxis joins Tech Tuesday panel discussion

EpiAxis joins Tech Tuesday panel discussion

EpiAxis Therapeutics CEO Dr Jeremy Chrisp this week joined Tech Tuesdays, a Canadian Securities Exchange virtual showcase that features in-depth discussions with companies shaking up the technology industry. The episode - Precision Medicine in Cancer Treatment - was a...

read more

 

Professor Sudha Rao